Skip to main content
Erschienen in: Osteoporosis International 10/2018

03.08.2018 | Original Article

Oral bisphosphonate prescription and non-adherence at 12 months in patients with hip fractures treated in an acute geriatric unit

verfasst von: A. Gamboa, E. Duaso, P. Marimón, M. Sandiumenge, E. Escalante, C. Lumbreras, A. Tarrida

Erschienen in: Osteoporosis International | Ausgabe 10/2018

Einloggen, um Zugang zu erhalten

Abstract

Summary

A poorer functional status at the time of fracture is a predictor of non-adherence to oral bisphosphonates initiated after a hip fracture, and suggests further opportunities for optimization of secondary fracture prevention in this high-risk population.

Introduction

Low adherence to treatment is a problem in post-fracture secondary prevention. We aimed to analyze the prognostic factors (related and predictive) associated with non-adherence to oral bisphosphonate prescription for hip fracture due to bone fragility (HFBF) 12 months after discharge from an acute geriatric unit.

Methods

Prospective study of bivariate data analyzing related and multivariate factors predicting non-adherence of oral bisphosphonates at 12 months after treatment for HFBF. The statistical study was performed with SPSS 19.0.0.

Results

We attended 368 patients with HFBF. At discharge, oral bisphosphonates were prescribed to 226 (61.42%) patients. At 12 months, we followed up 160 (70.7%) patients, 104 (65%) of whom had non-adherence to oral bisphosphonates. Bivariate analysis (adherent vs. non-adherent): age (83.79 ± 5.82 vs. 85.78 ± 5.80, p = .029); Lawton and Brody Index (4.29 ± 3.40 vs. 2.67 ± 3.31, p = .004); baseline Barthel Index (BI) (85.89 ± 21.99 vs. 74.18 ± 26.70) (p = .004); BI at admission (18.84 ± 10.00 vs. 14.47 ± 11.71, p = .004); BI at discharge (34.20 ± 15.40 vs. 27.45 ± 16.71, p = .011); baseline Functional Ambulation Classification (5.66 ± 0.98 vs. 5.43 ± 0.99, p = .025). Multivariate analysis: BI 0.980 (0.965–0.995, p = .007). Discriminatory capacity of the AUC model (± 95% CI): 0.634 (0.545–0.722).

Conclusions

At 12 months, there was low adherence to treatment with oral bisphosphonates in our model. A lower BI prior to treatment is a predictive factor for non-adherence treatment with oral bisphosphonate.
Literatur
1.
Zurück zum Zitat Cummings SR, Melton LJ (2002) Epidemiology and outcomes of osteoporotic fractures. Lancet (London, England) 359(9319):1761–1767 Cummings SR, Melton LJ (2002) Epidemiology and outcomes of osteoporotic fractures. Lancet (London, England) 359(9319):1761–1767
3.
Zurück zum Zitat Lee YK, Ha YC, Yoon BH, Koo KH (2013) Incidence of second hip fracture and compliant use of bisphosphonate. Osteoporos Int 24(7):2099–2104PubMed Lee YK, Ha YC, Yoon BH, Koo KH (2013) Incidence of second hip fracture and compliant use of bisphosphonate. Osteoporos Int 24(7):2099–2104PubMed
4.
Zurück zum Zitat Kim S-M, Moon Y-W, Lim S-J, Yoon B-K, Min Y-K, Lee D-Y, Park YS (2012) Prediction of survival, second fracture, and functional recovery following the first hip fracture surgery in elderly patients. Bone 50(6):1343–1350PubMed Kim S-M, Moon Y-W, Lim S-J, Yoon B-K, Min Y-K, Lee D-Y, Park YS (2012) Prediction of survival, second fracture, and functional recovery following the first hip fracture surgery in elderly patients. Bone 50(6):1343–1350PubMed
5.
Zurück zum Zitat Smith T, Pelpola K, Ball M, Ong A, Myint PK (2014) Pre-operative indicators for mortality following hip fracture surgery: a systematic review and meta-analysis. Age Ageing 43(4):464–471PubMed Smith T, Pelpola K, Ball M, Ong A, Myint PK (2014) Pre-operative indicators for mortality following hip fracture surgery: a systematic review and meta-analysis. Age Ageing 43(4):464–471PubMed
9.
Zurück zum Zitat Cenzer IS, Tang V, Boscardin WJ, Smith AK, Ritchie C, Wallhagen MI, Espaldon R, Covinsky KE (2016) One-year mortality after hip fracture: development and validation of a prognostic index. J Am Geriatr Soc 64:1863–1868PubMedPubMedCentral Cenzer IS, Tang V, Boscardin WJ, Smith AK, Ritchie C, Wallhagen MI, Espaldon R, Covinsky KE (2016) One-year mortality after hip fracture: development and validation of a prognostic index. J Am Geriatr Soc 64:1863–1868PubMedPubMedCentral
10.
11.
Zurück zum Zitat Henderson CY, Shanahan E, Butler A, Lenehan B, O’Connor M, Lyons D et al (2016) Dedicated orthogeriatric service reduces hip fracture mortality. Ir J Med Sci:1–6 Henderson CY, Shanahan E, Butler A, Lenehan B, O’Connor M, Lyons D et al (2016) Dedicated orthogeriatric service reduces hip fracture mortality. Ir J Med Sci:1–6
12.
Zurück zum Zitat Duaso E, Formiga F, Marimón P, Sandiumenge M, Salgado MT, Murga V, Gamboa A, Rodriguez C, Castellà J, Escalante E, Lumbreras C, Tarrida A, Sellarès R (2018) Advantages of care for patients with hip fractures in the acute geriatric unit: hip study Anoia. Geriatr Gerontol Int 18(3):407–414PubMed Duaso E, Formiga F, Marimón P, Sandiumenge M, Salgado MT, Murga V, Gamboa A, Rodriguez C, Castellà J, Escalante E, Lumbreras C, Tarrida A, Sellarès R (2018) Advantages of care for patients with hip fractures in the acute geriatric unit: hip study Anoia. Geriatr Gerontol Int 18(3):407–414PubMed
13.
Zurück zum Zitat Herrera M, Rodriguez E, Alvisa J, JL P (2013) Listado de comprobación al alta en la prevención de nuevas fracturas osteoporóticas de cadera. Rev Osteoporos Metab Min 5(1):7–14 Herrera M, Rodriguez E, Alvisa J, JL P (2013) Listado de comprobación al alta en la prevención de nuevas fracturas osteoporóticas de cadera. Rev Osteoporos Metab Min 5(1):7–14
15.
Zurück zum Zitat Cosman F (2009) Treatment of osteoporosis and prevention of new fractures: role of intravenously administered bisphosphonates. Endocr Pract 15(5):483–493PubMed Cosman F (2009) Treatment of osteoporosis and prevention of new fractures: role of intravenously administered bisphosphonates. Endocr Pract 15(5):483–493PubMed
16.
Zurück zum Zitat Kim SC, Kim M, Song HJ, Liu J, Hurtado I, Lee J et al (2016) Fracture: a Cross-National Study. 128(5):519–526 Kim SC, Kim M, Song HJ, Liu J, Hurtado I, Lee J et al (2016) Fracture: a Cross-National Study. 128(5):519–526
18.
Zurück zum Zitat Rabenda V, Vanoverloop J, Fabri V, Mertens R, Sumkay F, Vannecke C, Deswaef A, Verpooten GA, Reginster JY (2008) Low incidence of anti-osteoporosis treatment after hip fracture. J Bone Joint Surg Am 90(10):2142–2148PubMed Rabenda V, Vanoverloop J, Fabri V, Mertens R, Sumkay F, Vannecke C, Deswaef A, Verpooten GA, Reginster JY (2008) Low incidence of anti-osteoporosis treatment after hip fracture. J Bone Joint Surg Am 90(10):2142–2148PubMed
19.
Zurück zum Zitat Silverman SL, Gold DT, Cramer J (2007) a. Reduced fracture rates observed only in patients with proper persistence and compliance with bisphosphonates therapies. South Med J 100(12):1214–1218PubMed Silverman SL, Gold DT, Cramer J (2007) a. Reduced fracture rates observed only in patients with proper persistence and compliance with bisphosphonates therapies. South Med J 100(12):1214–1218PubMed
20.
Zurück zum Zitat Mahoney FI, Barthel DW (1965) Functional evaluation: the Barthel index. Md State Med J 14:61–65PubMed Mahoney FI, Barthel DW (1965) Functional evaluation: the Barthel index. Md State Med J 14:61–65PubMed
21.
Zurück zum Zitat Lawton MP, Brody EM (1969) Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 9(3):179–186PubMed Lawton MP, Brody EM (1969) Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 9(3):179–186PubMed
22.
Zurück zum Zitat Holden MK, Gill KM, Magliozzi MR, Nathan J, Piehl-Baker L (1984) Clinical gait assessment in the neurologically impaired reliability and meaningfulness. Phys Ther 64(1):35–40PubMed Holden MK, Gill KM, Magliozzi MR, Nathan J, Piehl-Baker L (1984) Clinical gait assessment in the neurologically impaired reliability and meaningfulness. Phys Ther 64(1):35–40PubMed
23.
Zurück zum Zitat Reisberg B, Ferris SH, de Leon MJ, Crook T (1982) The global deterioration scale for assessment of primary degenerative dementia. Am J Psychiatry 139(9):1136–1139PubMed Reisberg B, Ferris SH, de Leon MJ, Crook T (1982) The global deterioration scale for assessment of primary degenerative dementia. Am J Psychiatry 139(9):1136–1139PubMed
24.
Zurück zum Zitat Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373–383PubMed Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373–383PubMed
25.
Zurück zum Zitat Owens WD, Felts JA, Spitznagel ELJ (1978) ASA physical status classifications: a study of consistency of ratings. Anesthesiology 49(4):239–243PubMed Owens WD, Felts JA, Spitznagel ELJ (1978) ASA physical status classifications: a study of consistency of ratings. Anesthesiology 49(4):239–243PubMed
26.
Zurück zum Zitat Gregory PC, Lam D, Howell P (2010) Osteoporosis treatment following hip fracture: how rates vary by service. South Med J 103(10):977–981PubMed Gregory PC, Lam D, Howell P (2010) Osteoporosis treatment following hip fracture: how rates vary by service. South Med J 103(10):977–981PubMed
29.
Zurück zum Zitat Walters S, Khan T, Ong T, Sahota O (2017) Fracture liaison services: improving outcomes for patients with osteoporosis. Clin Interv Aging 12:117–127PubMedPubMedCentral Walters S, Khan T, Ong T, Sahota O (2017) Fracture liaison services: improving outcomes for patients with osteoporosis. Clin Interv Aging 12:117–127PubMedPubMedCentral
31.
Zurück zum Zitat Naranjo A, Ojeda-Bruno S, Bilbao-Cantarero A, Quevedo-Abeledo JC, Diaz-González BV, Rodríguez-Lozano C (2015) Two-year adherence to treatment and associated factors in a fracture liaison service in Spain. Osteoporos Int 26(11):2579–2585PubMed Naranjo A, Ojeda-Bruno S, Bilbao-Cantarero A, Quevedo-Abeledo JC, Diaz-González BV, Rodríguez-Lozano C (2015) Two-year adherence to treatment and associated factors in a fracture liaison service in Spain. Osteoporos Int 26(11):2579–2585PubMed
32.
Zurück zum Zitat Folbert EC, Hegeman JH, Vermeer M, Regtuijt EM, van der Velde D, Ten Duis HJ, et al. Improved 1-year mortality in elderly patients with a hip fracture following integrated orthogeriatric treatment. Osteoporos Int. 2016;1–9. Available from: https://doi.org/10.1007/s00198-016-3711-7 Folbert EC, Hegeman JH, Vermeer M, Regtuijt EM, van der Velde D, Ten Duis HJ, et al. Improved 1-year mortality in elderly patients with a hip fracture following integrated orthogeriatric treatment. Osteoporos Int. 2016;1–9. Available from: https://​doi.​org/​10.​1007/​s00198-016-3711-7
33.
Zurück zum Zitat Schaller F, Sidelnikov E, Theiler R, Egli A, Staehelin HB, Dick W, Dawson-Hughes B, Grob D, Platz A, Can U, Bischoff-Ferrari HA Mild to moderate cognitive impairment is a major risk factor for mortality and nursing home admission in the first year after hip fracture. Bone. 2012;51(3):347–352. Available from: https://doi.org/10.1016/j.bone.2012.06.004 Schaller F, Sidelnikov E, Theiler R, Egli A, Staehelin HB, Dick W, Dawson-Hughes B, Grob D, Platz A, Can U, Bischoff-Ferrari HA Mild to moderate cognitive impairment is a major risk factor for mortality and nursing home admission in the first year after hip fracture. Bone. 2012;51(3):347–352. Available from: https://​doi.​org/​10.​1016/​j.​bone.​2012.​06.​004
34.
Zurück zum Zitat Fukui N, Watanabe Y, Nakano T, Sawaguchi T, Matsushita T (2012) Predictors for ambulatory ability and the change in ADL after hip fracture in patients with different levels of mobility before injury: a 1-year prospective cohort study. J Orthop Trauma 26(3):163–171 Available from: http://www.ncbi.nlm.nih.gov/pubmed/21918484 PubMed Fukui N, Watanabe Y, Nakano T, Sawaguchi T, Matsushita T (2012) Predictors for ambulatory ability and the change in ADL after hip fracture in patients with different levels of mobility before injury: a 1-year prospective cohort study. J Orthop Trauma 26(3):163–171 Available from: http://​www.​ncbi.​nlm.​nih.​gov/​pubmed/​21918484 PubMed
35.
Zurück zum Zitat Dehamchia-Rehailia N, Ursu D, Henry-Desailly I, Fardellone P, Paccou J (2014) Secondary prevention of osteoporotic fractures: evaluation of the Amiens University Hospital’s fracture liaison service between January 2010 and December 2011. Osteoporos Int 25(10):2409–2416PubMed Dehamchia-Rehailia N, Ursu D, Henry-Desailly I, Fardellone P, Paccou J (2014) Secondary prevention of osteoporotic fractures: evaluation of the Amiens University Hospital’s fracture liaison service between January 2010 and December 2011. Osteoporos Int 25(10):2409–2416PubMed
Metadaten
Titel
Oral bisphosphonate prescription and non-adherence at 12 months in patients with hip fractures treated in an acute geriatric unit
verfasst von
A. Gamboa
E. Duaso
P. Marimón
M. Sandiumenge
E. Escalante
C. Lumbreras
A. Tarrida
Publikationsdatum
03.08.2018
Verlag
Springer London
Erschienen in
Osteoporosis International / Ausgabe 10/2018
Print ISSN: 0937-941X
Elektronische ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-018-4622-6

Weitere Artikel der Ausgabe 10/2018

Osteoporosis International 10/2018 Zur Ausgabe

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.